Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)

SHE:301033 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	288.76	272.26	227.54	195.02	153.79	123.51
Other Revenue	6.18	6.18	3.33	0.24	-	-
Revenue	294.94	278.44	230.87	195.25	153.79	123.51
Revenue Growth (YoY)	21.08%	20.61%	18.24%	26.96%	24.51%	9.07%
Cost of Revenue	61.29	57.63	41.58	31.26	27.29	20.82
Gross Profit	233.65	220.81	189.29	163.99	126.5	102.69
Selling, General & Admin	114.08	114.04	116.17	105.57	73	59.63
Research & Development	29.66	27.09	26.78	30.61	25.88	16.28
Other Operating Expenses	1.61	0.62	2.1	2.04	0.66	1.12
Operating Expenses	145.47	141.84	145.09	138.25	99.49	77.07
Operating Income	88.18	78.97	44.2	25.74	27.01	25.62
Interest Expense	-0.41	-0.9	-2.21	-1.78	-0.49	-
Interest & Investment Income	6.15	5.48	5.45	9.78	6.49	5.04
Currency Exchange Gain (Loss)	0.44	0.44	-0.01	1.04	-0.47	-0.23
Other Non Operating Income (Expenses)	-0.19	-0.26	-0.2	-0.13	-0.14	-0.13
EBT Excluding Unusual Items	94.17	83.72	47.24	34.65	32.4	30.31
Gain (Loss) on Sale of Investments	-0.68	0.15	0.13	-0.81	0.98	0.4
Gain (Loss) on Sale of Assets	0	0	-	0.17	0.01	0.08
Asset Writedown	-0.51	-0.48	-0.22	-1.29	-0.07	-0.65
Other Unusual Items	9.77	9.77	0.87	7.25	18.28	12.87
Pretax Income	102.75	93.16	48.02	39.96	51.6	43
Income Tax Expense	14.68	14.3	7.14	4.23	6.92	6.15
Earnings From Continuing Operations	88.07	78.85	40.88	35.73	44.68	36.86
Minority Interest in Earnings	-	-	-	0.16	0.03	0.11
Net Income	88.07	78.85	40.88	35.89	44.71	36.97
Net Income to Common	88.07	78.85	40.88	35.89	44.71	36.97
Net Income Growth	83.46%	92.90%	13.89%	-19.73%	20.95%	33.55%
Shares Outstanding (Basic)	66	66	66	66	57	49
Shares Outstanding (Diluted)	66	66	66	66	57	49
Shares Change (YoY)	0.54%	-0.33%	-0.80%	17.43%	14.83%	-0.28%
EPS (Basic)	1.34	1.20	0.62	0.54	0.79	0.75
EPS (Diluted)	1.33	1.20	0.62	0.54	0.79	0.75
EPS Growth	82.48%	93.55%	14.82%	-31.65%	5.33%	33.93%
Free Cash Flow	102.39	83.22	67.6	-87.65	-86.2	-27.74
Free Cash Flow Per Share	1.55	1.27	1.02	-1.32	-1.52	-0.56
Dividend Per Share	0.600	0.600	0.400	0.200	0.100	-
Dividend Growth	50.00%	50.00%	100.00%	100.00%	-	-
Gross Margin	79.22%	79.30%	81.99%	83.99%	82.25%	83.14%
Operating Margin	29.90%	28.36%	19.15%	13.18%	17.56%	20.74%
Profit Margin	29.86%	28.32%	17.71%	18.38%	29.08%	29.93%
Free Cash Flow Margin	34.72%	29.89%	29.28%	-44.89%	-56.05%	-22.46%
EBITDA	113.84	104.28	68.11	38.99	33.18	30.66
EBITDA Margin	38.60%	37.45%	29.50%	19.97%	21.57%	24.82%
D&A For EBITDA	25.66	25.31	23.91	13.25	6.17	5.04
EBIT	88.18	78.97	44.2	25.74	27.01	25.62
EBIT Margin	29.90%	28.36%	19.15%	13.18%	17.56%	20.74%
Effective Tax Rate	14.29%	15.35%	14.88%	10.58%	13.41%	14.29%
Revenue as Reported	294.94	278.44	230.87	195.25	153.79	123.51
Advertising Expenses	-	19.07	32.56	43.12	23.01	19.84

Source: S&P Global Market Intelligence. Standard template. Financial Sources.